· AHRQ/PCORI Learning Health System Small Grant Pilot Program
(PA-21-202)
Agency for Healthcare Research and Quality
Application Receipt Date(s): June 16, 2022
· Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
(PAR-21-122)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
· Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
(PAR-21-123)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
· Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
(PAR-21-124)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): Multiple dates, see announcement.
· Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-21-163)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
· Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
(PAR-21-190)
National Cancer Institute
Application Receipt Date(s): Multiple dates, see announcement.
· New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
(PAS-21-150)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
· Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes. (U01) Clinical Trials Not Allowed
(RFA-FD-21-022)
Food and Drug Administration
Application Receipt Date(s): May 17, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
· Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed
(RFA-FD-21-033)
Food and Drug Administration
Application Receipt Date(s): May 18, 2021, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
· Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
(RFA-MD-21-005)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): May 3, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
· Innovations for Healthy Living – Improving Minority Health and Eliminating Health Disparities (R43/R44 – Clinical Trial Optional)
(RFA-MD-21-006)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): May 3, 2021 No late applications will be accepted for this Funding Opportunity Announcement.
· BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-21-130)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Multiple dates, see announcement.
· BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
(RFA-MH-21-135)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Multiple dates, see announcement.
· Limited Competition to Convert the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Study Cohort to a Research Resource (R24 – Clinical Trial Not Allowed)
(RFA-MH-21-170)
National Institute of Mental Health
National Institute on Aging
National Institute on Drug Abuse
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 10, 2021
· HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
(RFA-NS-21-015)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Application Receipt Date(s): April 27, 2021, June 22, 2021, October 13, 2021, June 9, 2022, October 11, 2022, June 9, 2023, and October 10, 2023 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
· HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
(RFA-NS-21-016)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Application Receipt Date(s): April 27, 2021
· Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
(RFA-OD-21-003)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Application Receipt Date(s): October 8, 2021, August 8, 2022, March 8, 2023
· Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
(RFA-OD-21-004)
National Institutes of Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
National Institutes of Health
Application Receipt Date(s): October 8, 2021, August 8, 2022, March 8, 2023
